Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

Thermo Fisher Scientific Acquires Brammer Bio for $1.7 Billion

March 25, 2019

Biotechnology

Thermo Fisher Scientific agreed to acquire Brammer Bio, a viral vector CDMO focused on gene and cell therapies, for approximately $1.7 billion in cash. The deal expands Thermo Fisher’s pharma services and viral vector manufacturing capabilities to support high-growth gene and cell therapy markets and brings a team of nearly 600 employees into its pharma services business.

Thermo Fisher Scientific to Acquire Clario Holdings for $8.875 Billion

October 29, 2025

Healthcare Services

Thermo Fisher Scientific has announced an agreement to buy Clario Holdings, a provider of digital endpoint data solutions for clinical trials, for $8.875 billion in cash plus up to $400 million in earnout payments. The acquisition is expected to close by mid-2026, subject to regulatory approvals, and will expand Thermo Fisher’s digital capabilities for pharma and biotech clinical research.

Thermo Fisher Scientific Acquires Solventum's Purification & Filtration Business

September 2, 2025

Manufacturing

Thermo Fisher Scientific completed the acquisition of Solventum's Purification & Filtration business for approximately $4.0 billion in cash. The divested business—now Thermo Fisher's Filtration and Separation business—adds bioprocessing filtration, industrial filtration and membrane technologies to Thermo Fisher's Life Sciences Solutions portfolio and is expected to generate about $750 million in revenue in 2025.

Thermo Fisher Scientific Acquires Olink Holding AB

July 10, 2024

Biotechnology

Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.

Alcami Corporation Acquires Pacific Pharmaceutical Services

January 17, 2024

Healthcare Services

Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.

NFI Corp. Acquires PPS Inc.

July 7, 2021

Manufacturing

NFI Corp., a New Bedford, Massachusetts-based producer of custom printed graphic solutions, has acquired PPS Inc., a printed-graphics and printed-electronics manufacturer headquartered in Olathe, Kansas. NFI will relocate PPS's manufacturing to its New Bedford facility while maintaining a sales and administrative office in Kansas; the acquisition is intended to expand NFI's capabilities and customer base in the U.S.